1Notarbartolo A;Davi G;Averna M.Inhibition of the omboxane biosynthesis and platelet function by simvastation in type Ⅱ a type cholesterolemia,1995(02). 被引量:1
2Indolfi C;Di Lorenzo E;Perrino C.Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevent cardiac hypertrophy induced by pressure overload and inhibits p21 ras activation[J],2002(16). 被引量:1
3Carvalho AC;Colman RW;Lees RS.Platelet function in hyperlipoproteinemia,1974(08). 被引量:1
4Undas A;Brummel KE;Musial J.Simvastation depresses blood clotting activation of prothrombin,factor V,and factor Ⅻ and by enhancing factor Va in activation[J],2001(18). 被引量:1
5Baetta R;Camera M;Compaeato C.Fluvastation reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering,2002(04). 被引量:1
6Ardissino D;Merlini PA;Ariens R.Tissue-factor antigen and activity in human coronary atherosclerotic plaques,1997(9054). 被引量:1
7Takemoto M;Node K;Nakagami H.Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy,2001(10). 被引量:2
8Wagner AH;Kohler T;Ruckschloss U.Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation[J],2000(01). 被引量:1
9Laufs U;Endres M;Stagliano N.Neuroprotection mediated by changes in the endothelial actin cytoskeleton[J],2000(01). 被引量:1
10Assmus B;Urbich C;Aicher A.HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes[J],2003(09). 被引量:1